arrow
返回

Tuberous sclerosis complex

delete2016-05-26
delete479
PRE
AI
E
Elizabeth P. Henske *
S
Sergiusz Jóźwiak
J
J.C. Kingswood
J
Julian R. Sampson
E
Elizabeth A. Thiele
DOI:10.1038/nrdp.2016.35delete
delete原文链接
delete分享
delete收藏
摘要

摘要

En 中文
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder that affects multiple organ systems and is caused by loss-of-function mutations in one of two genes: TSC1 or TSC2. The disorder can affect both adults and children. First described in depth by Bourneville in 1880, it is now estimated that nearly 2 million people are affected by the disease worldwide. The clinical features of TSC are distinctive and can vary widely between individuals, even within one family. Major features of the disease include tumours of the brain, skin, heart, lungs and kidneys, seizures and TSC-associated neuropsychiatric disorders, which can include autism spectrum disorder and cognitive disability. TSC1 (also known as hamartin) and TSC2 (also known as tuberin) form the TSC protein complex that acts as an inhibitor of the mechanistic target of rapamycin (mTOR) signalling pathway, which in turn plays a pivotal part in regulating cell growth, proliferation, autophagy and protein and lipid synthesis. Remarkable progress in basic and translational research, in addition to several randomized controlled trials worldwide, has led to regulatory approval of the use of mTOR inhibitors for the treatment of renal angiomyolipomas, brain subependymal giant cell astrocytomas and pulmonary lymphangioleiomyomatosis, but further research is needed to establish full indications of therapeutic treatment. In this Primer, we review the state-of-the-art knowledge in the TSC field, including the molecular and cellular basis of the disease, medical management, major knowledge gaps and ongoing research towards a cure.
Keyword:
POLYCYSTIC KIDNEY-DISEASE
GIANT-CELL ASTROCYTOMA
SPORADIC PULMONARY LYMPHANGIOLEIOMYOMATOSIS
MICRONODULAR PNEUMOCYTE HYPERPLASIA
TSC CLINICAL RECOMMENDATIONS
AUTISM SPECTRUM DISORDERS
RENAL ANGIOMYOLIPOMA
MAMMALIAN TARGET
NATURAL-HISTORY
MOUSE MODEL
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

N
Nature Reviews Disease Primers
IF:
60.6
论文数:
663
被引数:
4.8W

机构

U
university of brighton
学者数:
85
论文数: 52
被引数: 2.4K
M
Medical University of Warsaw
学者数:
471
论文数: 180
被引数: 2.7K
H
Harvard University
学者数:
7.2K
论文数: 2.5K
被引数: 20.7W
学者 查看更多机构
引用论文

引用论文

err分享
err收藏
Relationship of perfusion to edema in the 9L gliosarcoma
err1993-04-01
err0
PREAI
errR. Grant Steen; Sharon Kromhout-Schiro; Michael M. Graham
err分享
err收藏
err分享
err收藏
err
IF0
err
err0
PREAI
err
err分享
err收藏
Everolimus alters white matter diffusion in tuberous sclerosis complex
err2012-02-21
err63
PREAI
errTillema, Jan-Mendelt; Leach, James L.; Krueger, Darcy A.; Franz, David Neal
err分享
err收藏
学者 查看更多内容